市場調查報告書
商品編碼
1569494
眼科器材市場規模、佔有率和成長分析:按產品、按應用、按最終用途、按地區 - 行業預測,2024-2031 年Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2024-2031 |
2022年全球眼科器材市場規模估值為283.3億美元,從2023年的295.2億美元增加至2031年的362.6億美元,預測期間(2024-2031)預計複合年成長率為4.2%。
由於光學相干斷層掃描(OCT)和眼底成像等診斷影像技術的進步,提高了眼科疾病的靈敏度和早期檢測能力,預計眼科診斷設備市場將顯著成長。除了這些技術進步之外,諸如微切口白內障手術(MICS)和雷射輔助屈光等微創手術技術的趨勢也在不斷成長,而市場對提高準確性、安全性和縮短恢復時間的需求也在增加。此外,醫療保健支出的增加,特別是在新興經濟體,正在推動先進眼科技術和程序的採用,但上市時間和合遵循成本方面仍然存在挑戰。全球人口老化的人口變化,預計2022年65歲以上人口將達到7.71億,2050年將增至16億,這也是推動市場成長的一個極為重要的因素。老年人數量迅速增加,特別是在非洲和拉丁美洲等地區,與患有各種疾病(包括心血管疾病)的風險增加有關。這些人口趨勢代表了眼科設備領域的重大市場機會,因為醫療保健系統越來越注重提供先進的診斷和治療,以滿足人口老化的需求。因此,技術創新、外科手術進步和人口變化的結合為眼科診斷設備產業的成長提供了強勁的前景。
Global Ophthalmology Devices Market size was valued at USD 28.33 Billion in 2022 and is poised to grow from USD 29.52 Billion in 2023 to USD 36.26 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).
The ophthalmic diagnostic devices market is poised for significant growth driven by ongoing advancements in imaging technologies like Optical Coherence Tomography (OCT) and fundus imaging, enhancing the sensitivity and early detection of ocular diseases. This technological progress is coupled with the rising trend toward minimally invasive surgical techniques, such as microincision cataract surgery (MICS) and laser-assisted refraction procedures, known for their improved accuracy, safety, and quicker recovery times, which further fuels market demand. Additionally, growing healthcare expenditures, particularly in emerging economies, are facilitating the adoption of sophisticated ophthalmic technologies and procedures, although challenges related to time to market and compliance costs remain. The demographic shift towards an aging global population, projected to reach 771 million individuals aged 65 and older by 2022, with numbers expected to escalate to 1.6 billion by 2050, is another pivotal factor driving market growth. The rapid increase of elderly individuals, particularly in regions such as Africa and Latin America, correlates with a heightened risk of developing various diseases, including cardiovascular ailments. This demographic trend underscores a significant market opportunity within the ophthalmic devices sector, as healthcare systems increasingly focus on providing advanced diagnostics and treatments to address the needs of an aging population. Thus, the combination of technological innovations, surgical advancements, and demographic shifts suggests a robust landscape for growth in the ophthalmic diagnostic devices sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the global ophthalmology devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
global ophthalmology devices Market Segmental Analysis
Based on the product, the ophthalmology devices market is segmented into surgical & vision care. By application the ophthalmology devices market is segmented into cataract and glaucoma. Based on the end-user, the global market is segmented into hospitals, ophthalmic clinics, eye clinics and others. Geographically, the global ophthalmology devices market has been segmented into Asia-Pacific, North America, Europe, and the Middle East & Africa, and Latin America.
Driver of the global ophthalmology devices Market
The rising incidence of eye infections and related discomfort is a significant driver for the global ophthalmology devices market. With an increase in pollution levels and the prevalence of irritants-such as smoke, dust, and harsh cosmetics-the demand for reliable diagnostic and therapeutic ophthalmology devices is surging. Conditions like blepharitis and dry eyes further exacerbate the need for effective interventions. Moreover, growing awareness of ocular health and continuous advancements in the pharmaceutical sector enhance the urgency for innovative ophthalmic devices, thereby increasing market growth. As eye health becomes a priority for consumers and healthcare providers alike, the market is poised for expansion.
Restraints in the global ophthalmology devices Market
The global ophthalmology devices market faces significant restraints due to several factors prevalent in emerging countries. A decrease in per capita healthcare expenditure hampers the ability to invest in advanced ophthalmic treatments and technologies. Additionally, limited product accessibility restricts the distribution and adoption of innovative devices, further impeding patient care. Compounding these challenges is a lack of awareness regarding ophthalmic diseases, leading to a lower number of patients seeking necessary treatments. For instance, disparities in surgical rates, such as the cataract surgery procedures observed in China compared to the U.S., illustrate the existing limitations that hinder market growth in these regions.
Market Trends of the global ophthalmology devices Market
The global ophthalmology devices market is experiencing robust growth, driven by the increasing demand for innovative equipment, accessories, and contact lenses among healthcare professionals and patients. Notably, advancements such as micro-invasive glaucoma surgeries (MIGs) have emerged as a rapidly growing segment, catering to the treatment needs for mild to moderate glaucoma. Furthermore, market players are directing their efforts toward developing advanced micro-invasive cataract surgical implants, which are expected to enhance surgical outcomes and patient satisfaction. This trend highlights a shift toward less invasive procedures, ultimately propelling the expansion of the ophthalmic devices market in the coming years.